Laurus Labs got listed on the stock markets on Thursday with a premium of 14.46% over its issue price. At the NSE, stock opened at Rs 489.90 a share as against issue price of Rs 428.00 a share.
Currently, shares are trading at Rs 477.45, up 11.55% from its issue price. It recorded a high of Rs 498 and a low of Rs 475 at the NSE (10:07 am).
Laurus Labs is Hyderabad based pharmaceutical company. Laurus Labs is in the business of manufacturing generic active pharmaceutical ingredients (APIs) for therapeutic areas of antiretrovirals (ARVs) and Hepatitis C. Company also manufactures APIs in oncology and other therapeutic areas.